Monisha Kandala

Ms. Monisha Kandala

Division of Infectious Diseases and Geographic Medicine and Dept of Infectious diseases., UT Southwestern Medical Center, Dallas, Texas, USA
orcid

Research Focus & Metrics

Representative Publications

View All Publications
7 December 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
AKArnaud John Kombe Kombe
Arnaud John Kombe Kombe
LFLeila Fotoohabadi
Leila Fotoohabadi
YGYulia Gerasimova
Yulia Gerasimova
RNRavikanth Nanduri
Ravikanth Nanduri
PTPratik Lama Tamang
Pratik Lama Tamang
TKTheodoros Kelesidis
Theodoros Kelesidis
Viral respiratory infections (VRIs) are a leading cause of morbidity and mortality worldwide, making them a significant public health concern. During infection, respiratory viruses, including Influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV), trigger an antiviral immune response, specifically boosting the inflammatory response that plays a critical role in their pathogenesis. The inflammatory response induced by respiratory viruses can be a double-edged sword since it can be initially induced to be antiviral and protective/reparative from virus-induced injuries. Still, it can also be detrimental to host cells and tissues. However, the mechanisms that differentiate the complex crosstalk between favorable host inflammatory responses and harmful inflammatory responses are poorly understood. This review explores the complex interplay between viral pathogens and the host immune response, mainly focusing on the role of inflammation in the pathogenesis of VRIs. We discuss how inflammation can both contain and exacerbate the progression of viral infections, highlighting potential therapeutic targets and emerging drugs for modulating the aberrant inflammatory responses during VRIs.